| Tag | Content |
|---|
EnhancerAtlas ID | HS182-09513 |
Organism | Homo sapiens |
Tissue/cell | Spleen |
Coordinate | chr17:45342880-45343910 |
| | Number of super-enhancer constituents: 6 | ID | Coordinate | Tissue/cell |
| SE_01825 | chr17:45343389-45344080 | Aorta | | SE_44528 | chr17:45342406-45345554 | NHDF-Ad | | SE_46007 | chr17:45342260-45346087 | Osteoblasts | | SE_56088 | chr17:45341285-45345708 | u87 | | SE_60223 | chr17:45306684-45357937 | Ly4 | | SE_67842 | chr17:45341285-45345708 | u87 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr17 | 45343282 | 45343909 | | chr17 | 45342941 | 45343065 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH17I047265 | chr17 | 45342636 | 45346329 |
|
Enhancer Sequence | CATTCTCTCT ATATGTCTCT CTCTTCGTGT GGTGTTTTCC TCTTCTCATA AGGACATCAG 60
TCATGTTGGA TTAGGGCCTA CCCTAACGAC ATCAATTGAT CACATCTGCA AAGACCTGAT 120
TTCTCTGTAA GGTCATGGTC ATGGGCACTG GGGTAAGGAC TTCAACATAT CTTTTTTGGG 180
GACATAAGTC AACTTATAAC ACATTTTAAT ATTGGTGGAG GCAAGTTATA CACAAATGTT 240
TTCCAATGTT AAATACCGTA CTTAACTGGC TCTGATATAC TTAAAAACAG TTTTAAATCT 300
CTAAAATCAG GACATATACT ATATTCATAG TGTTAGATTT GATGAAATAT GGTGCCTGGG 360
TTCTCTACTG CTTTGGGTGA TGCTTACTGG AGCTTTTTGC TCAGAGCACA GAGGTATGTG 420
TTACCCTAAA CTCCACCTCC CTGTCTCCTT CTCCTTCCTT GGGTTACTTA GCTGATGCTA 480
CATTTAAGGA AGGACCAAAA TTAAAATAAA CTTTCTTAGC AACTTGCTCT AGATAAACCA 540
CTTGTGCCTA TGTAGGACAG TAAGCATGAG ATTTTTTTTT TTCATGAGTC ACATGGCCAG 600
GTGACTACAA TGAGGCATCA TGTGAGTCAC CCACTGTCCC CATGGACCTA ATTGGGAAGT 660
GAGCAGTCAA AGGTCAGTGG CAGGGCTGGG GACCCAGATT AGAACTCCTT TCTGGCAGAG 720
TGATAGATGT CCATAGTGTT AGTGGAACAT CCTCCCTTCT CGATAAACAC CTCTTACTGT 780
GACTTAGCCC TCTCCTGTAG TCCCCTGTCC TCATTAGGGT GGCCTGTTCC TACAGTCCAG 840
CATCCTGTCT CACTGGACAA CATGTCCTCA AAATAGCCCC CATTGACGCA TTATGACTTC 900
CACTGGATCC AATTCCCTCC CTTGTTTCCT TTGTTCTTCC ATTTTTCCCA CCCTTTGTCT 960
CTCTTCTGCT TCTGTGATTC AAGCTGATGT GCCAAACCAC AGCCTTCTAC TTCTACTTTC 1020
CAGGCAAACT 1030
|
